Works matching IS 03407004 AND DT 2013 AND VI 62 AND IP 1
Results: 19
T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 27, doi. 10.1007/s00262-012-1303-8
- By:
- Publication type:
- Article
FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 17, doi. 10.1007/s00262-012-1306-5
- By:
- Publication type:
- Article
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 137, doi. 10.1007/s00262-012-1317-2
- By:
- Publication type:
- Article
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 125, doi. 10.1007/s00262-012-1319-0
- By:
- Publication type:
- Article
MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 191, doi. 10.1007/s00262-012-1376-4
- By:
- Publication type:
- Article
Distinct in vivo CD8 and CD4 T cell responses against normal and malignant tissues.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 101, doi. 10.1007/s00262-012-1316-3
- By:
- Publication type:
- Article
A knockdown of Maml1 that results in melanoma cell senescence promotes an innate and adaptive immune response.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 183, doi. 10.1007/s00262-012-1318-1
- By:
- Publication type:
- Article
CXCL12 is a costimulator for CD4 T cell activation and proliferation in chronic lymphocytic leukemia patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 113, doi. 10.1007/s00262-012-1320-7
- By:
- Publication type:
- Article
B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 87, doi. 10.1007/s00262-012-1313-6
- By:
- Publication type:
- Article
Generation and immunologic functions of Th17 cells in malignant gliomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 75, doi. 10.1007/s00262-012-1312-7
- By:
- Publication type:
- Article
Memory T cells are uniquely resistant to melanoma-induced suppression.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 149, doi. 10.1007/s00262-012-1326-1
- By:
- Publication type:
- Article
Looking to the future of cancer immunotherapy: many questions to answer and many therapeutic opportunities.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 51, doi. 10.1007/s00262-012-1300-y
- By:
- Publication type:
- Article
Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 65, doi. 10.1007/s00262-012-1311-8
- By:
- Publication type:
- Article
'Tumor Immunology Meets Oncology (TIMO) VIII' from May 4 to 5, 2012, in Halle/Saale, Germany.
- Published in:
- 2013
- By:
- Publication type:
- Report
Increased prevalence of tumor-infiltrating regulatory T cells is closely related to their lower sensitivity to HO-induced apoptosis in gastric and esophageal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 161, doi. 10.1007/s00262-012-1327-0
- By:
- Publication type:
- Article
High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 3, doi. 10.1007/s00262-012-1295-4
- By:
- Publication type:
- Article
Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 171, doi. 10.1007/s00262-012-1322-5
- By:
- Publication type:
- Article
Lenalidomide enhances anti-myeloma cellular immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 39, doi. 10.1007/s00262-012-1308-3
- By:
- Publication type:
- Article